Control Bionics (ASX:CBL) share price doubles after successful IPO

The Control Bionics Limited (ASX:CBL) share price is rocketing higher after completing its IPO this morning…

A medical researcher works on a bichip, indicating share price movement in ASX tech companies

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Control Bionics Limited (ASX: CBL) share price landed on the ASX boards this morning following the successful completion of its initial public offering (IPO). And what a start it has had!

At the time of writing, the medical technology company's shares are fetching $1.21.

This is more than double the Control Bionics listing price of 60 cents.

What is Control Bionics?

Control Bionics is a medical technology company founded by former CNN anchor, Peter Ford.

Whilst working at CNN, Mr Ford taught himself to code and, inspired by Stephen Hawking, began developing software that would allow severely disabled people to operate and communicate using only their thoughts and neural signals.

The company notes that this technology is making a huge difference to the lives of those using it.

Furthermore, it has now gone well beyond basic communication and can allow those with diseases such as motor neurone disease (MND) to do things that haven't been possible for a long time. This includes gaming, controlling a television, and continuing with careers.

An example of the latter is Professor Justin Yerbury, who was recognised in this year's Australia Day honours list for his outstanding contribution to research regarding MND.

Using Control Bionic's NeuroNode system, Mr Yerbury has been able to continue teaching and researching in his field of Neurodegenerative Diseases at Wollongong University.

In FY 2020, the company generated $3.1 million in product revenue, which represented growth of 297% on FY 2019. And despite challenges presented by COVID-19, it has achieved unaudited revenue growth of approximately 41% in the first quarter compared to the prior corresponding period.

The Control Bionics IPO.

Control Bionics' IPO raised a total of $15 million at $0.60 per new share. This gave the company a $50 million market cap.

Management revealed that demand was so strong for its IPO that it was restricted to priority offer applications only after just a week.

Speaking about the offering, Chairman Roger Hawke commented: "The funds raised by this Offer will provide Control Bionics with working capital to execute our growth strategy in North America, increase our presence in Australia and prepare for entry to other priority markets including Japan. Additionally, funds will be used to support the marketing for existing products and to fund continued development of the hardware and software for a range of new, advanced applications."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of CBL Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »